Clinical Trial Update: Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial compares irofulven to fluorouracil in pancreatic cancer, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Irofulven (irofulven)

Snippet

Sponsor: Eisai Inc. | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED